Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM CIPLA OMKAR PHARMACHEM/
CIPLA
 
P/E (TTM) x 116.1 32.8 353.9% View Chart
P/BV x 2.5 4.0 61.5% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 OMKAR PHARMACHEM   CIPLA
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
CIPLA
Mar-22
OMKAR PHARMACHEM/
CIPLA
5-Yr Chart
Click to enlarge
High Rs211,083 1.9%   
Low Rs16806 2.0%   
Sales per share (Unadj.) Rs0.3269.7 0.1%  
Earnings per share (Unadj.) Rs0.231.7 0.7%  
Cash flow per share (Unadj.) Rs0.244.8 0.5%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs8.6257.8 3.3%  
Shares outstanding (eoy) m10.08806.81 1.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.43.5 1,951.8%   
Avg P/E ratio x83.329.8 279.8%  
P/CF ratio (eoy) x82.921.1 393.0%  
Price / Book Value ratio x2.13.7 58.1%  
Dividend payout %015.8 0.0%   
Avg Mkt Cap Rs m185762,177 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m135,299 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3217,633 0.0%  
Other income Rs m03,217 0.0%   
Total revenues Rs m3220,851 0.0%   
Gross profit Rs m043,298 0.0%  
Depreciation Rs m010,520 0.0%   
Interest Rs m11,064 0.1%   
Profit before tax Rs m034,933 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-39,338 -0.0%   
Profit after tax Rs m225,595 0.0%  
Gross profit margin %8.119.9 40.6%  
Effective tax rate %714.726.7 2,673.7%   
Net profit margin %82.011.8 697.3%  
BALANCE SHEET DATA
Current assets Rs m1147,108 0.0%   
Current liabilities Rs m1049,129 0.0%   
Net working cap to sales %-332.145.0 -737.7%  
Current ratio x0.13.0 2.4%  
Inventory Days Days12,57263 19,998.9%  
Debtors Days Days3656 6,355.3%  
Net fixed assets Rs m93119,415 0.1%   
Share capital Rs m1011,614 6.2%   
"Free" reserves Rs m-14206,364 -0.0%   
Net worth Rs m87207,977 0.0%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m94266,523 0.0%  
Interest coverage x0.433.8 1.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.8 3.5%   
Return on assets %3.010.0 29.7%  
Return on equity %2.612.3 20.8%  
Return on capital %0.217.0 1.4%  
Exports to sales %026.2 0.0%   
Imports to sales %08.2 0.0%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs mNA17,803 0.0%   
Fx inflow Rs m060,180 0.0%   
Fx outflow Rs m017,803 0.0%   
Net fx Rs m042,376 0.0%   
CASH FLOW
From Operations Rs m033,259 0.0%  
From Investments Rs mNA-18,719 0.0%  
From Financial Activity Rs mNA-15,998 0.0%  
Net Cashflow Rs m0-1,323 -0.0%  

Share Holding

Indian Promoters % 0.0 13.5 0.2%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 0.0 49.0 -  
FIIs % 0.0 27.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 66.4 150.6%  
Shareholders   3,561 418,910 0.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.